Furthermore, we found that NPRA-KO mice do not permit growth of implanted human lung cancer, melanoma and ovarian cancer cells [19], suggesting that NPRA may be a novel therapeutic candidate. The gene discussed is NPR1; the disease is lung carcinoma.